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Abstract: 
The rise and growth of Systems Biology following the sequencing of the human genome has 
been astounding. Early on, an iterative wet-dry methodology was formulated which turned 
out as a successful approach in deciphering biological complexity. Such type of analysis 
effectively identified and associated molecular network signatures operative in biological 
processes across different systems. Yet, it has proven difficult to distinguish between causes 
and consequences, thus making it challenging to attack medical questions where we require 
precise causative drug targets and disease mechanisms beyond a web of associated markers. 
Here we review principal advances with regard to identification of structure, dynamics, 
control, and design of biological systems, following the structure in the visionary review 
from 2002 by Dr. Kitano. Yet, here we find that the underlying challenge of finding the 
governing mechanistic system equations enabling precision medicine remains open thus 
rendering clinical translation of systems biology arduous. However, stunning advances in raw 
computational power, generation of high-precision multi-faceted biological data, combined 
with powerful algorithms hold promise to set the stage for data-driven identification of 
equations implicating a fundamental understanding of living systems during health and 
disease. 
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In our view, systems biology has now become an accepted paradigm in biological research 
[1]. This is in part reflected in the sheer number and quality of publications utilizing systems 
approaches acknowledging and embracing the complexity of biology [2–4]. Recently, the 
application of such frameworks to clinical challenges has led to the emergence of what could 
be referred to as systems or network medicine [1,5,6]. It is therefore timely to ask to what 
extent real progress has been achieved -  and to critically assess the nature of conceptual and 
technical hurdles remaining in meeting the needs from a medical standpoint. Here, we use 
the structure of the very influential position paper (close to 4000 citations) by Kitano in 2002 
[7] to assess achievements and challenges on the basis of the research agendas put forward. 
Next, on the basis this analysis we argue that despite conceptual and technical advances, 
there remains a fundamental gap between finding associated features (biomarkers) of a 
given process versus the more challenging task obtaining a causal (e.g. mechanistic) 
understanding of the process. This, in our view an ultimate gap, becomes even more glaring 
in a medical context, since there we would like to ask therapeutic questions such as what 
happens if we do X to a (human) system. At the end of the day, X is an intervention based on 
causal understanding in the sense that “if X is executed” then “the relevant processes 
become properly modified”. We conclude this opinion paper with the sentiment that the 
time is ripe for bridging this gap and algorithmic tools in combination with richer data and 
more powerful computational platforms have the potential to operationally address the 
inherent challenges in wordings such as ‘relevant’ and ‘properly’ above.  
 
Systems-based analysis a la Kitano. 
Since the sequencing of the human genome, there has been a shift in biomedical research 
from reductionism towards a holistic view in the sense of acknowledging the complexity and 
myriad of parallel and interconnected processes, including the multiple spatio-temporal 
scales involved in almost any biological phenomena. Interestingly, technological advances 
rather than theory itself have largely driven this shift of perspective. It has generated a 
multitude of novel methodologies (or creative applications of existing methodologies), many 
of them labeled under the fields of Systems Biology [7] or Systems Medicine [8,9]. While 
multiple complementary definitions of Systems Biology do exist [10,11], we frame our 
discussion using the landmark paper from Prof. Kitano in 2002 [7]. Prof. Kitano provided a 
comprehensive concept, and what could be referred to as a normative account, in turn 
translated into an operational pipeline defining Systems Biology as a methodology to 
understand biological systems. Specifically, an iterative standpoint was formulated such that 
a cycle of research combining dry-lab and wet-lab efforts would generate, validate or reject 
a hypothesis, and finally incorporated the outcomes of the analysis in the state-of-the-art 
amenable for a new iteration of the cycle. In this, Prof. Kitano emphasized four necessary 
vital avenues of investigations that jointly would admit system-level understanding: (1) 
system structures (for instance the network of interactions), (2) system dynamics 
(mathematical description and analysis), (3) control method (identification of the biological 
targets that can modulate or control the state of the cell) and a (4) design method (aiming to 
construct systems de novo to make use or to validate properties identified or hypothesis 
generated). Remarkably, in hindsight the 2002 Kitano’s vision has turned out to be truly 
predictive in that we have witnessed remarkable progress in all those four areas, yet at 
different pace, and in part evolving in separate communities. For example, the emergence of 
the young dynamic filed of synthetic biology can be viewed as response to the need for 
design, which in turn can be traced back to Feynman’s classic dictum on what you can’t 
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create you don't understand. At this juncture, we could conceptually ask whether these four 
areas are necessary, sufficient, or both to achieve systems understanding [12]. To shed light 
on this issue we will first briefly review progress in respective area, finding that the 
aforementioned gap between biomarkers and mechanisms cuts across all four areas. 
 
Structure, Dynamics, Control, and Design – progress and gaps. 
In engineering, or more specifically control theory, system identification is defined as a 
method for developing mathematical and computer-based models that represent the 
characteristics of that system from measurements of the system inputs and outputs [13]. 
Traditionally, linear systems have been in focus and the mathematical model captures the 
transfer function between input and output, thus not necessarily incorporating neither the 
underlying biophysical components nor the non-linear dynamics governing the interactions 
between the components over time. In contrast, in biology we aspire to identify not only the 
structure of cellular networks but also their dynamics, in order to achieve engineered 
control of the system [14,15]. This motivates the division of labor between finding the 
structure, dynamics, and control respectively as originally conceptualized by Kitano. The 
identification of System Structures can be attained by data-driven reverse-engineering 
approaches [16], either augmented by prior knowledge as a structural scaffold or by direct 
experimental analysis requiring structural learning directly from the data[17]. With the 
advent of high-throughput technologies – including both microarray and Next-Generation 
Sequencing technologies, reverse-engineering approaches have been a major research area 
in systems biology since the original 2002 publication. Pure data-driven reverse-engineering 
methods have as a rule only used time-series and/or perturbation experiments to uncover 
associations - not necessarily causal - between features e.g a transcription factor and the 
expression of the corresponding target genes [18]. Such relationships can readily be 
represented using different modelling formalisms, such as Mutual information [11], Boolean 
networks, Bayesian networks (BNs) [12], Petri nets [19], constraint-based models, 
differential equations [20], rule-based models [21], cellular automata or agent-based models 
[22], all being parts of a growing toolkit for data-driven reverse-engineering approaches. Yet, 
causal parameterizing remains challenging due to uncertainties in model structure and 
parameters [23]. A second line of reasoning is to define a prior network structure or scaffold 
through a literature review. Examples include modeling of atherosclerosis modeling [20], 
brain functioning [24], or immune system [25] to name a few examples among many. 
Alternative, the prior structural template can be collected from systematic experiments, as 
in the case of Protein-Protein interactions and the generation of the Proteome-Scale Map of 
the Human Interactome Network [17]. From the three approaches, experimental and data-
driven approaches are in our view to become even more prevalent due to the exponential 
growth of data in public repositories [26–28] and the decrease cost in sequencing [29]. The 
knowledge-based approach appears to be at a turning point in the sense that “classical” 
text-mining methodologies [30,31] have not, in our view, provided a significant edge when 
compared with other approaches, whereas recent advances using DeepLearning [32] 
methodologies hold promise to disrupt current state-of-the-art in text mining similarly to 
recent achievements in genomic analysis [33,34]. In summary, these advances in network 
biology have enriched the notion of biomarker from a single or very few features to include 
a larger set of (inter-connected) features (i.e. a network signature) associated with disease 
or a biological process. In contrast, to achieve a mathematical description of a biological 
system from first or derived principles has been challenging ever since the pioneering work 
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of Hodgkin-Huxley and still constitutes a fundamental barrier. If we are unable to have what 
could be referred to as fundamental guiding principles to model dynamic biological 
processes and how these are controlled (e.g least action principle in physics) and given that 
we are dealing with large inter-connected living systems the challenge is how to formulate 
unbiased mathematical models under these modeling conditions. Regardless of how the 
interactions between elements are represented, the importance of system dynamics 
remains as illustrated by the central dogma of Systems Biology: “system dynamics that gives 
rise to the functioning and function of cells” [35]. One of the best examples is the pioneering 
work by Tyson and colleagues on the cell-cycle in different systems [36,37]. For this problem, 
it is imperative to model and understand the Systems Dynamics, i.e. what governs the 
switch from one phase to another, as it is dependent on the dynamics between many 
variables, which is different in each of the phases of the cell cycle. A wiring diagram is simply 
not sufficient. Such a systems dynamics analysis requires: (a) an accurate definition of the 
system structure [23], and analysis of how variations of the structure may affect the 
dynamics [38,39], (b) a mathematical parameterization, linear or non-linear [40], (c) a 
mathematical analysis such as the bifurcation analysis [41] or the identification of slow 
manifolds [12,42], and (d) sensitivity analysis of structure and parameters in the model using 
the system dynamics as a readout [43,44]. From experience within the community, we 
would like to argue that essential factors for success includes dealing with a “small confined” 
system (e.g the cell cycle or nerve impulse propagation) combined with physical insights 
enabling a simplified or reduced (phenomenological) description of the system at hand. Yet, 
despite this, in our hands any such analysis targeting system dynamics sooner or later is 
challenged by the conundrum on: “how to generate hypothesis under uncertainty in both 
structure and dynamics?”. This becomes exponentially challenging the larger system is and 
the less experimental constraints we can in principle impose on the state-variables and 
parameters governing the system dynamics. In our view, because of these difficulties the 
issue of uncertainty has mainly been addressed in the area of Control Method where ‘what 
if’ kind of questions are as a rule being asked aiming to uncover what controls, as a rule, a 
small confined system. Broadly speaking, meeting this challenge, investigators have 
developed two different approaches: ordinary differential equations (ODE) based dynamical 
models versus structural network-based models. Using ODE, the challenge of generating 
hypothesis under uncertainty is an active field of research [45], and methods are emerging 
for exploring the space of feasible models [23,39] explaining existing data, and generating 
robust hypothesis by their study [20,46,47].  In the case of network-models, the majority of 
models or wiring diagrams, such as Protein-Protein interactions [17,48], gene-gene 
interactions or co-morbidity oriented models [49], suffer from the lack of dynamics because 
the modeling framework is an interactome-based description of the system. However, 
interactome or structural models are in many cases considered as systems biology models – 
or as a “gateway to systems biology”[50] – because they provide some insights into control 
aspects by identifying for instance: (a) candidates for master regulators [41] in highly 
connected genes or genes with a high betweeness centrality value [51] (measures the 
centrality of a node in a network by its prevalence in the shortest paths between other 
nodes); (b) identifying groups of highly connected nodes associated to a specific functional 
role or disease [48]; or, among others, (c) identifying recurrent motifs [52] in the network 
that may be associated to robustness [7]. Yet, a wiring diagram is not sufficient to address 
what happens if those nodes or edges are modified, i.e. causal interventions are as a rule 
beyond the scope of such models. In our experience, and very importantly, both approaches, 
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ODE and Network-based models, can be complementary. A first-order approach is simply to 
use network-approaches combined with knowledge-based methods to select the most 
relevant features (nodes and edges) to be incorporated in a dynamical model [53]. A major 
bottleneck for such an approach is that, in most cases, the information used for variable 
selection may not suffice for the generation of accurate mathematical models [54]. We like 
to argue that a critical but fair assessment, is that while dynamical system analysis and 
causal control analysis has been ongoing in the modeling community those efforts have not 
been successfully adopted in systems medicine [55] or impacted the clinical community. This 
is not surprising since this state-of-affairs reflect the current gap between network 
biomarkers and a true causal understanding of a system [12].   
The fourth area of Design Method, pointed out by Kitano, entails the use of combined in-
silico and wet-lab strategies to design new systems [56] or to-modify existing systems on-
demand [57]. In this regards, Synthetic Biology plays a fundamental role in Systems Biology 
because it opens the door to investigate basic design principles in biological systems [58,59]. 
Interestingly, some investigators consider Synthetic biology as a logical end point of Systems 
Biology [10]. Several milestones have been achieved since 2002, including the generation of 
a minimal bacterial cell, an 531-kb genome encoding 438 proteins and 35 RNAs [60]. 
Additionally, several techniques allows several degrees of manipulation, such as silencing 
RNA [61], shRNA and CRISPR-Cas9 [62,63] perturbation methodologies. Moreover, several 
advances in synthetic biology are already approaching clinical utility [64]. An impressive line-
up of success stories has enabled interventions and reprogramming of systems without 
requiring complete systems understanding.  
 
Timely to close the gap between network biomarkers and causal mechanisms? 
In the previous section, we have briefly enumerated some advances since 2002 in Systems 
Biology (and Systems Medicine) with special reference to structure, dynamics, control, and 
design. Yet, there are several practical, technical, and conceptual hurdles impeding smooth 
transition and iterations of the Kitano cycle. These include for instance: (i) insufficient 
amount and quality of data supporting not only accurate reconstruction of the network 
structure of a system but importantly the generation of accurate mechanistic models [16]; 
(ii) many of the methodologies proposed were prohibitory computationally expensive. 
Additionally, (iii) the research community has uncovered many regulatory layers, beyond PPI 
or TF-gene interactions that are required to be included in any faithful biological model. For 
example, epigenetic regulations [65,66], chromatin accessibility [67] or transcriptional 
control exerted by miRNAs [68], thus making the problem of formulating a dynamical model 
even more difficult. Hence, the astute reader may well ask why should we believe that it is 
timely to advance beyond network biomarkers to dynamical models capable of addressing 
causal or therapeutic interventions in “large” systems? 
In our view, we have attained a technological stage where hypothesis driven research in 
Systems Biology is becoming (or can become) a reality. We now highlight the most relevant 
elements that could spur such a development: 
 Computational speed: in the year of 2000, Pentium 4 was the new Intel Processor, 
and in contrasts, 2015 the latest Intel processor was not only 84x times faster [69] 
but also significantly cheaper. Furthermore, recent advances in the utilization of 
GPUs have fueled large-scale parallel computations [70]. These developments clearly 
support massive ensemble approaches [38] and computational-driven parameter 
explorations [39] that previously were restricted to supercomputer centers. 
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Importantly, in addition to the continuous increase in computational power following 
Moore’s law, high-performance computing centers centralized in large institutions 
and cloud-based systems, such as Amazon Web Services 
(https://aws.amazon.com/hpc/), are complementing and eventually replacing small 
and medium computational solutions to a large extent. It is clear that research teams 
have access to affordable powerful computational resources at an unprecedented 
scale compared to a decade ago. In summary, the sheer size and the number of 
models that can explored in any given application is now enhanced by several orders 
of magnitude. 
 Size and variety of data-types: the advent of NGS technologies initially provided the 
tools for whole genome sequencing [71] and a better estimation of mRNA expression 
[72] but soon, applications were extended to all DNA or RNA associated regulatory 
layers such as Transcription Factor Binding or Histone marks profiles by ChIP-seq 
[73], miRNA sequencing [68], Chromatin Accessibility [74] or DNA Methylation [65] 
among others. Through the combination of several NGS technologies we have in 
principle access to a complete regulatory view of a biological system or disease, and 
existing large-scale collaborative projects such as TCGA, ENCODE, IHEC or STATegra 
[75] are examples in that direction. Hence, the capacity to capture the relevant 
correlated features in a given process has improved dramatically. 
 Increased biological resolution in data: Microarray and NGS technologies were 
originally capable of generating molecular profiles by averaging across several 
millions of cells per sample. For example, the expression profile estimated from 
millions of cells, masking cell-to-cell variation, has been a serious concern when 
analyzing heterogeneous tumors. Fortunately, recent advances in single-cell 
technologies, such as C1 Fluidigm, Drop-seq or 10X Genomics, are completely 
changing the game [76–79]. Most importantly, single-cell technologies are not 
exclusively targeting RNA-seq but other omics such as DNA Methylation [80], 
Chromatin Conformation [81,82], and efforts are currently conducted to profile 
several omics data-types from the same cell [83]. A second major value of single-cell 
techniques is that we can profile large number of single cells, within budgetary limits, 
which in the context of sample-hungry reverse-engineering algorithms is a major 
advantage. In essence, single cell techniques hold the promise of delivering a 
fundamental description of cells and their dynamics, thus setting the stage for 
modeling larger systems as well as accelerating designer or synthetic biology 
approaches. 
 Method development: Yet, despite the technical advances referred to above we 
would like to emphasize that there is a deep need for developing powerful 
algorithms and computational modeling techniques in close alignment with the new 
types of high-precision data while making use of the new computational raw power. 
We have witnessed such kind of synergistic method evolution during the last two 
decades in the area of network analysis [84–86]. Furthermore, there has been 
advances in mechanistic modeling, analysis [45] and visualization [87]. From our 
point of view, the most relevant and timely challenge is still the systematic 
generation of in-silico derived causal hypothesis in larger systems in the face of 
uncertainty which is addressed in detail in [45]. 
 Workforce: Systems Biology clearly requires multi-skilled groups, covering multiple 
fields from mathematics to biology and even more so when entering the medical 
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domain. While over the years courses and communities [88,89] responding to these 
needs have developed, there is still a need for funding soft infrastructures including 
education to further nurture the advances and communication across knowledge 
silos to properly integrate and support advanced data-analysis close to biology and 
medicine.  
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Conclusions: 
Systems Biology has evolved over the last two decades to become a practical methodology 
taking center stage in the analysis of complex biological processes. Much has developed 
along the lines of Kitano´s prophetic vision. Here we have made the point out why the 
remaining gaps and bottlenecks existing at the beginning of the 21
st
 century are ready to be 
bridged. The overarching remaining challenge is level the field towards a quantitative and 
dynamical account of biological processes during health and disease. Dramatic 
improvements in raw computational power, rich high-precision multi-level data in 
conjunction with new advanced algorithms hold the promise to bridge the gap between 
associated biomarkers and mechanistic elucidation of the governing processes. It is 
therefore timely that systems-based approaches, using a combined and integrative in-silico 
and experimental approach, address this gap and in doing so setting the stage to advance 
systems biology into targeting medical challenges in high precision [90,91]. Key here for drug 
development and personalized medicine is our ability to identify causal mechanisms 
enabling robust precise therapeutic interventions beyond enumerating single biomarkers or 
network signatures. Last, but critical, as enablers of such work crossing traditional 
boundaries is the need for multi-skilled research teams, or collaborations, that make use of 
all tools and resources [91].  
As a conclusion, we are truly excited to be part of this era in the analysis of living systems 
during health and disease, where systems-based research and techniques can further 
revolutionize the all-changing biomedical research field, possibly even beyond what Kitano 
could imagine after the sequencing of the human genome  
 
  
Captions: 
Figure 1. Reviewing Hypothesis-driven research in systems biology. The inner circle 
reproduces Kitano’s classical Iterative System Biology workflow. The outer boxes denote 
gaps and current advances and tools mitigating those gaps.  
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Hypothesis driven research combining dry and wet-lab requires a new generation of 
scientists in a fast-changing and data-oriented research environment. 
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• A review in 2017 of Systems Biology through visionary Kitano’s 2002 work. 
• The gaps in hypothesis driven research and the existing tools to overcome 
them. 
• Future of Systems Medicine. 
 
 
